 Neoplasm Invasiveness
"Neoplasm Invasiveness" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
| Descriptor ID |
D009361
|
| MeSH Number(s) |
C04.697.645 C23.550.727.645
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Invasiveness".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Invasiveness".
This graph shows the total number of publications written about "Neoplasm Invasiveness" by people in this website by year, and whether "Neoplasm Invasiveness" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1982 | 0 | 1 | 1 | | 1983 | 0 | 1 | 1 | | 1985 | 0 | 2 | 2 | | 1986 | 0 | 4 | 4 | | 1989 | 0 | 3 | 3 | | 1991 | 0 | 1 | 1 | | 1992 | 0 | 4 | 4 | | 1993 | 0 | 7 | 7 | | 1994 | 0 | 5 | 5 | | 1995 | 0 | 6 | 6 | | 1996 | 0 | 4 | 4 | | 1997 | 1 | 3 | 4 | | 1998 | 1 | 4 | 5 | | 1999 | 1 | 6 | 7 | | 2000 | 0 | 7 | 7 | | 2001 | 0 | 7 | 7 | | 2002 | 1 | 5 | 6 | | 2003 | 2 | 6 | 8 | | 2004 | 6 | 6 | 12 | | 2005 | 1 | 12 | 13 | | 2006 | 0 | 12 | 12 | | 2007 | 6 | 11 | 17 | | 2008 | 1 | 15 | 16 | | 2009 | 3 | 9 | 12 | | 2010 | 1 | 12 | 13 | | 2011 | 1 | 16 | 17 | | 2012 | 0 | 20 | 20 | | 2013 | 2 | 15 | 17 | | 2014 | 1 | 19 | 20 | | 2015 | 0 | 29 | 29 | | 2016 | 0 | 16 | 16 | | 2017 | 2 | 12 | 14 | | 2018 | 3 | 15 | 18 | | 2019 | 1 | 6 | 7 | | 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Neoplasm Invasiveness" by people in Profiles.
-
Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ, Bleicher RJ, Lyons JA, Sarantou T, Baron PL, Stevens RE, Boolbol SK, Anderson BO, Shulman LN, Gradishar WJ, Monticciolo DL, Plecha DM, Nelson H, Yao KA. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020 Jun; 181(3):487-497.
-
Morita S, Kamimura K, Abe H, Watanabe-Mori Y, Oda C, Kobayashi T, Arao Y, Tani Y, Ohashi R, Ajioka Y, Terai S. Pulmonary tumor thrombotic microangiopathy of hepatocellular carcinoma: A case report and review of literature. World J Gastroenterol. 2019 Dec 28; 25(48):6949-6958.
-
Schmid P, Rugo HS, Adams S, Schneeweiss A, Barrios CH, Iwata H, Diéras V, Henschel V, Molinero L, Chui SY, Maiya V, Husain A, Winer EP, Loi S, Emens LA. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2020 01; 21(1):44-59.
-
Pitroda SP, Weichselbaum RR. Integrated molecular and clinical staging defines the spectrum of metastatic cancer. Nat Rev Clin Oncol. 2019 09; 16(9):581-588.
-
Zhao L, Westerhoff M, Hornick JL, Krausz T, Antic T, Xiao SY, Hart J. Loss of microfibril-associated protein 5 (MFAP5) expression in colon cancer stroma. Virchows Arch. 2020 Mar; 476(3):383-390.
-
Mukhija D, Nagpal SJS, Sohal DPS. Epidemiology, Tumor Characteristics, and Survival in Patients With Primary Pancreatic Lymphoma: A Large Population-based Study Using the SEER Database. Am J Clin Oncol. 2019 05; 42(5):454-458.
-
Shah HA, Fischer JH, Venepalli NK, Danciu OC, Christian S, Russell MJ, Liu LC, Zacny JP, Dudek AZ. Phase I Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) in Combination With Selective VEGFR Inhibitor Pazopanib for Therapy of Advanced Solid Tumors. Am J Clin Oncol. 2019 05; 42(5):413-420.
-
James BC, Timsina L, Graham R, Angelos P, Haggstrom DA. Changes in total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer during the past 15 years. Surgery. 2019 07; 166(1):41-47.
-
Henley SJ, Miller JW, Dowling NF, Benard VB, Richardson LC. Uterine Cancer Incidence and Mortality - United States, 1999-2016. MMWR Morb Mortal Wkly Rep. 2018 Dec 07; 67(48):1333-1338.
-
Werntz RP, Adamic B, Steinberg GD. Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC). World J Urol. 2019 Oct; 37(10):2031-2040.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|